Trip.com Group Limited · TCOM · FY2025 Q1 · Calendar Q2 2025
Trip.com: resilient travel demand supports growth, with macro risks
The supplied analysis is directionally supportive of Trip.com’s growth outlook: resilient travel demand, inbound expansion, AI-enabled engagement, and new product categories provide evidence for continued momentum. The case remains conditional because guidance was not provided and macro, foreign-exchange, competitive, and policy risks could weaken results.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about TCOM FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis emphasizes inbound travel growth, TripGenie engagement, senior-traveler and experience-focused products, mobile-app expansion, Middle East growth, and continued capital returns. Compared with the prior analysis, the risk discussion places more emphasis on AI-agent effectiveness, tariff and foreign-exchange volatility, membership competition, and corporate-travel sensitivity.
Guidance delta
No guidance delta was provided in the supplied analysis.
Key takeaways
- Management described resilient travel demand and highlighted inbound travel as a fast-growing segment.
- AI tools, mobile-app adoption, senior travel, and experience-led products were presented as growth drivers.
- The analysis supports a constructive operating view, but macro volatility and competition remain important uncertainties.
Management priorities
- Enhance AI capabilities and add AI-driven tools.
- Grow mobile-app share and direct user acquisition in APAC and beyond.
- Expand senior-focused and experience-driven travel offerings.
- Continue geographic expansion, particularly in the Middle East and Europe.
- Maintain share buybacks and dividend payouts.
Follow TCOM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Macquarie | Outperform | Neutral | Upgrade | Sep 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 17, 2026 |
| StoneX | Buy | Buy | Maintain | Sep 16, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| China Renaissance | Hold | Buy | Downgrade | Jul 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 26, 2026 |
| Benchmark | Buy | Buy | Maintain | Jun 25, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 26, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 29, 2025 |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| HSBC | Buy | Hold | Upgrade | Nov 19, 2024 |
| CLSA | Buy | Buy | Maintain | May 13, 2024 |
| UBS | Buy | Buy | Maintain | Feb 22, 2024 |
| Nomura Instinet | Neutral | Buy | Downgrade | Nov 21, 2023 |
| Daiwa Capital | Buy | Outperform | Maintain | Jun 9, 2023 |
| New Street Research | Buy | Neutral | Upgrade | Jan 4, 2022 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | May 17, 2021 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 19, 2021 |
| CMB International | Buy | Buy | Maintain | Dec 18, 2020 |
| New Street | Neutral | Buy | Downgrade | Dec 3, 2020 |
| Credit Suisse | Outperform | Neutral | Upgrade | Nov 11, 2020 |
| ICBC Research | Neutral | Buy | Downgrade | Sep 15, 2020 |
| BTIG | Neutral | Neutral | Maintain | Jun 11, 2020 |
| Nomura | Buy | Neutral | Upgrade | May 29, 2020 |
| Bank of America | Buy | Buy | Maintain | Sep 11, 2019 |
| Jefferies | Buy | Buy | Maintain | Aug 5, 2019 |
| Wells Fargo | Perform | Market Perform | Maintain | Sep 6, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 5, 2018 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 26, 2018 |
| Guggenheim | Neutral | Buy | Downgrade | Jan 23, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Aug 28, 2017 |
| Brean Capital | Buy | Buy | Maintain | Jun 16, 2016 |
| Singular Research | Sell | Sell | Maintain | Feb 1, 2016 |
| Raymond James | Buy | Outperform | Maintain | Nov 13, 2015 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Aug 28, 2015 |
| Summit Research Partners | Hold | Hold | Maintain | Apr 20, 2015 |
| PiperJaffray | Outperform | Neutral | Upgrade | Apr 7, 2015 |
| Aegis Capital | Hold | Buy | Downgrade | Aug 1, 2014 |
| Standard Chartered Bank | Underperform | In Line | Downgrade | Nov 6, 2013 |
| TH Capital | Buy | Hold | Upgrade | Oct 29, 2013 |
| Credit Agricole | Buy | Outperform | Maintain | May 9, 2013 |
| JG Capital | Neutral | Neutral | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $40.01. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Macquarie | Analyst unavailable | $52.2 | $40.43 | +30.5% | Sep 17, 2026 |
| Mizuho Securities | James Lee | $60 | $39.25 | +50.0% | Sep 16, 2026 |
| HSBC | Parash Jain | $48 | $41.38 | +20.0% | Sep 3, 2026 |
| Jefferies | Thomas Chong | $63 | $44.77 | +57.5% | Jul 28, 2026 |
| Barclays | Analyst unavailable | $60 | $40.49 | +50.0% | Jun 26, 2026 |
| Macquarie | Ellie Jiang | $44.3 | $40.49 | +10.7% | Jun 26, 2026 |
| Barclays | Jiong Shao | $75 | $52.12 | +87.5% | Feb 26, 2026 |
| Morgan Stanley | Yang Liu | $75 | $52.33 | +87.5% | Feb 26, 2026 |
| Barclays | Jiong Shao | $90 | $72.44 | +124.9% | Nov 19, 2025 |
| Bernstein | Analyst unavailable | $78 | $75.03 | +95.0% | Aug 29, 2025 |
| Barclays | Analyst unavailable | $85 | $75.03 | +112.4% | Aug 29, 2025 |
| Mizuho Securities | Analyst unavailable | $81 | $75.03 | +102.4% | Aug 28, 2025 |
| Barclays | Jiong Shao | $84 | $64.97 | +109.9% | May 16, 2025 |
| Macquarie | Ellie Jiang | $80.8 | $41.88 | +101.9% | Nov 19, 2024 |
| CFRA | Siti Salikin | $80 | $41.88 | +100.0% | Nov 19, 2024 |
| HSBC | Parash Jain | $75 | $41.88 | +87.5% | Nov 19, 2024 |
| Bernstein | Boris Van | $85 | $67.24 | +112.4% | Nov 4, 2024 |
| Citigroup | Brian Gong | $72 | $62.39 | +80.0% | Oct 10, 2024 |
| Macquarie | Ellie Jiang | $75.4 | $68.43 | +88.5% | Oct 7, 2024 |
| Morgan Stanley | Yang Liu | $61 | $51.14 | +52.5% | Sep 25, 2024 |
| Jefferies | Thomas Chong | $75 | $45.93 | +87.5% | Aug 27, 2024 |
| Morgan Stanley | Alex Poon | $64 | $52.75 | +60.0% | May 24, 2024 |
| CFRA | Siti Salikin | $66 | $52.31 | +65.0% | May 23, 2024 |
| Barclays | Jiong Shao | $76 | $54.5 | +90.0% | May 22, 2024 |
| Mizuho Securities | James Lee | $65 | $57.05 | +62.5% | May 21, 2024 |
| Jefferies | Thomas Chong | $70 | $57.05 | +75.0% | May 21, 2024 |
| Mizuho Securities | James Lee | $55 | $35.91 | +37.5% | Jan 17, 2024 |
| Jefferies | Thomas Chong | $48 | $37.53 | +20.0% | Mar 7, 2023 |
| UBS | Analyst unavailable | $41 | $34.82 | +2.5% | Dec 16, 2022 |
| Barclays | Analyst unavailable | $35 | $27.66 | -12.5% | Sep 28, 2022 |
| Goldman Sachs | Simon Cheung | $33.3 | $25.76 | -16.8% | Sep 13, 2022 |
| Citigroup | Analyst unavailable | $32 | $27.22 | -20.0% | Jun 29, 2022 |
| Mizuho Securities | Analyst unavailable | $30 | $24.57 | -25.0% | Jun 28, 2022 |
| Barclays | Jiong Shao | $33 | $29.59 | -17.5% | Feb 9, 2022 |
| New Street | Jin Yoon | $30 | $25.69 | -25.0% | Jan 4, 2022 |
| Jefferies | Thomas Chong | $34 | $22.45 | -15.0% | Dec 16, 2021 |
| Benchmark Co. | Fawne Jiang | $44 | $29.07 | +10.0% | Sep 24, 2021 |
| Credit Suisse | Ivy Ji | $47 | $35.59 | +17.5% | Jun 28, 2021 |
| Nomura | Jialong Shi | $48 | $41.02 | +20.0% | May 19, 2021 |
| Oppenheimer | Jed Kelly | $45 | $39.44 | +12.5% | May 18, 2021 |
Track every rating change on TCOM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTrip.com Group Limited stands as a leading global travel service provider, operating extensively both within China and across international markets. Through its various subsidiaries, the company offers a comprehensive spectrum of travel-related solutions. As a booking intermediary, it facilitates hotel accommodations and air ticket purchases, complementing these with access to train, long-distance bus, and ferry tickets. The firm enhances the travel experience with various value-added services, including a range of travel insurance products (covering aspects like flight delays, accidents, and baggage loss), along with conveniences such as ticket delivery, online check-in, seat selection, expedited security, real-time flight tracking, and airport VIP lounge access. Catering to leisure travelers, Trip.com Group curates diverse packaged tour products, from organized group excursions and semi-private trips to fully customized itineraries.…
Historical context
All TCOM earningsLatest beats and misses
Who reports nextBeat on EPS
Get the TCOM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-05-05T00:04:36.652619+00:00
- Polygon adjusted daily market bars · 2026-10-17T15:50:41.509865+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T15:50:41.507040+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.